Relative Strength Chart Quoin Pharmaceuticals, Ltd.
Equities
QNRX
US74907L4095
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.38 USD | -2.67% |
|
-15.03% | -28.10% |
| 12-05 | Top Premarket Decliners | MT |
| 11-11 | Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| QUOIN PHARMACEUTICALS, LTD. | Other Biotechnology & Medical Research | -2.67% | -15.03% | -28.10% | -49.72% | - | 8.94M |  | | |
- Stock Market
- Equities
- QNRX Stock
- Charts Quoin Pharmaceuticals, Ltd.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition